Serum Institute of India likely front-runner to win supply of HPV vaccines for UIP, says GlobalData
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
The vaccine will be manufactured and marketed in the Philippines by SII under the brand name Covovax
The vaccine can be stored at 2 to 8 degrees celsius and traditional cold chain capabilities will suffice
BB will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets
The first lot of IPV will be supplied to the government this month as per the requirement of the Health Ministry
Serum buys 50 per cent stake in Indian joint venture of SCHOTT Kaisha
Filing for WHO Emergency Use Authorisation this month
Biocon Biologics Limited will have access to 100 million doses of vaccines annually together with the distribution rights to Serum's Vaccine portfolio
Malaria is a life-threatening parasitic infection that is spread by the bites of mosquitoes carrying the Plasmodium parasite
India is working towards augmenting health infrastructure and have initiated multiple schemes to strengthen health systems and improve health service delivery
Subscribe To Our Newsletter & Stay Updated